Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy

Authors

Kitipong Uaesoontrachoon, Children's National Medical Center
James L. Quinn, Children's National Medical Center
Kathleen Tatem, Children's National Medical Center
Jack H. Van der Meulen, Children's National Medical Center
Qing Yu, Children's National Medical Center
Aditi Phadke, George Washington University
Brittany K. Miller
Heather A. Gordish-Dressman, George Washington University
Ennio Ongini
Daniela Miglietta
Kanneboyina Nagaraju, George Washington University

Document Type

Journal Article

Publication Date

2014

Journal

Human Molecular Genetics

Volume

Volume 23, Issue 12

Inclusive Pages

3239-3249

Keywords

Heart Function Tests--drug effects; Muscular Dystrophy, Duchenne--drug therapy; Muscular Dystrophy, Duchenne--physiopathology; Naproxen--analogs & derivatives; Nitric Oxide Donors--administration & dosage

APA Citation

Uaesoontrachoon, K., Quinn, J.L., Tatem, K.S., Van der Meulen, J.H., Yu, Q. et al. (2014). Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy. Human Molecular Genetics, 23(12), 3239-3249.

Peer Reviewed

1